Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial

Copy For Citation

Sellier-Leclerc A., Magen D., Shasha-Lavsky H., Simkova E., Devresse A., Guebre-Egziabher F., ...More

American Journal of Kidney Diseases, 2025 (SCI-Expanded)

• Publication Type: Article / Letter
• Publication Date: 2025
• Doi Number: 10.1053/j.ajkd.2025.01.016
• Journal Name: American Journal of Kidney Diseases
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE
• Gazi University Affiliated: Yes